McGill JB

References (4)

Title : Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study - McGill_2013_Diabetes.Care_36_237
Author(s) : McGill JB , Sloan L , Newman J , Patel S , Sauce C , von Eynatten M , Woerle HJ
Ref : Diabetes Care , 36 :237 , 2013
Abstract : McGill_2013_Diabetes.Care_36_237
ESTHER : McGill_2013_Diabetes.Care_36_237
PubMedSearch : McGill_2013_Diabetes.Care_36_237
PubMedID: 23033241

Title : Liraglutide: effects beyond glycaemic control in diabetes treatment - McGill_2010_Int.J.Clin.Pract.Suppl__28
Author(s) : McGill JB
Ref : Int J Clin Pract Suppl , :28 , 2010
Abstract : McGill_2010_Int.J.Clin.Pract.Suppl__28
ESTHER : McGill_2010_Int.J.Clin.Pract.Suppl__28
PubMedSearch : McGill_2010_Int.J.Clin.Pract.Suppl__28
PubMedID: 20887302

Title : Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes - McGill_2009_Postgrad.Med_121_46
Author(s) : McGill JB
Ref : Postgrad Med , 121 :46 , 2009
Abstract : McGill_2009_Postgrad.Med_121_46
ESTHER : McGill_2009_Postgrad.Med_121_46
PubMedSearch : McGill_2009_Postgrad.Med_121_46
PubMedID: 19179813

Title : The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes - Triplitt_2007_J.Manag.Care.Pharm_13_S2
Author(s) : Triplitt C , McGill JB , Porte D, Jr. , Conner CS
Ref : J Manag Care Pharm , 13 :S2 , 2007
Abstract : Triplitt_2007_J.Manag.Care.Pharm_13_S2
ESTHER : Triplitt_2007_J.Manag.Care.Pharm_13_S2
PubMedSearch : Triplitt_2007_J.Manag.Care.Pharm_13_S2
PubMedID: 18062735